Clinical Applications: Chronic viral infections (hepatitis B/C, Lyme disease) Immune deficiency states Cancer immunotherapy support Autoimmune condition modulation Recovery from severe illness or surgery Dosing: Typically 1.6-3.2 mg subcutaneously, 2-3 times per week for immune support, or daily for acute conditions
Substantial human trial data for full-length TB-4 (corneal-healing Phase 2/3 as RGN-259, plus cardiac and wound-repair programs), with clean Phase 1 safety. Cosmetic dosing is extrapolated from these programs
Why were they motivated to look for what eventually became bpc
In 2026, an expanding body of clinical evidence is examining how specific peptides interact with the hormonal and metabolic systems that disproportionately affect women particularly those navigating PCOS, perimenopause, insulin resistance, and thyroid dysfunction
The antioxidant properties of glutathione translate into several benefits for skin
The control group demonstrated minimal improvement and recovery
